Schcolnik CA, Hernández CR, Vega MME, Arenas GR, Fernández MRF

Idioma: Español
Referencias bibliográficas: 28
Paginas: 311-316
Archivo PDF: 283.81 Kb.

RESUMEN

La lipotransferencia es un método que ha evolucionado dentro del área de la cirugía estética y reconstructiva para modificar el contorno corporal del individuo; sin embargo, se ha asociado ocasionalmente con infecciones con diverso grado de morbimortalidad. Reportamos dos casos de pacientes a quienes se les realizó una lipotransferencia de la zona abdominal y la cintura hacia las nalgas, y que cursaron con infección posquirúrgica. Mediante reacción en cadena de la polimerasa (PCR) del ADN extraído de una muestra de tejido y de un cultivo, con posterior secuenciación, se identificaron como agentes causales Mycobacterium chelonae y M. massiliense.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Dessy LA, Mazzocchi M, Fioramonti P, Scuderi N. Conservative management of local Mycobacterium chelonae infection after combined liposuction and lipofilling. Aesthetic Plast Surg. 2006;30(6):717-22.

2. Sterodimas A, de Faria J, Nicaretta B, Pitanguy I. Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg. 2010;63(11):1886-92.

3. Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose- derived stem/stromal cells. Aesthetic Plast Surg. 2008;32(1):48-55.

4. Pereira LH, Sterodimas A. Autologous fat transplantation and delayed silicone implant insertion in a case of Mycobacterium avium breast infection. Aesthetic Plast Surg. 2010;34(1):1-4.

5. Douvoyiannis M, Litman N, Dulau A, Ilowite NT. Panniculitis, infection, and dermatomyositis: case and literature review. Clin Rheumatol. 2009;28(1):57-63.

6. Illouz YG, Sterodimas A. Autologous fat transplantation to the breast: a personal technique with 25 years of experience. Aesthetic Plast Surg. 2009;33(5):706-15.

7. Sterodimas A, de Faria J, Nicaretta B, Papadopoulos O, Papalambros E, Illouz YG. Cell-assisted lipotransfer. Aesthet Surg J. 2010;30(1):78-81.

8. Tiwari TS, Ray B, Jost KC Jr, et al. Forty years of disinfectant failure: outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin Infect Dis. 2003;36(8):954-62.

9. Murillo J, Torres J, Bofill L, et al. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Arch Dermatol. 2000;136(11):1347-52.

10. Neyrolles O, Hernández-Pardo R, Pietri-Rouxel F, et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS One. 2006;1:e43.

11. Lim JM, Kim JH, Yang HJ. Management of infections with rapidly growing mycobacteria after unexpected complications of skin and subcutaneous surgical procedures. Arch Plast Surg. 2012;39(1):18-24.

12. del Solar M, Salomón M, Bravo F, et al. Infección cutánea por micobacterias atípicas de crecimiento rápido (MACR) debido a mesoterapia cosmética. Reporte de casos y revisión de la literatura. Folia Dermatol Peru. 2005;16(3):127-35.

13. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53(4):1367-76.

14. Viana-Niero C, Lima KV, Lopes ML, et al. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. J Clin Microbiol. 2008;46(3):850-5.

15. Chopra S, Matsuyama K, Hutson C, Madrid P. Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. J Antimicrob Chemother. 2011;66(7):1533-6.

16. Ripoll F, Deshayes C, Pasek S, et al. Genomics of glycopeptolipid biosynthesis in Mycobacterium abscessus and M. chelonae. BMC Genomics. 2007;8:114.

17. Malcolm KC, Nichols EM, Caceres SM, et al. Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival. PLoS One. 2013;8(2):e57402.

18. Lee HM, Yuk JM, Kim KH, et al. Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62/SQSTM1. Immunol Cell Biol. 2012;90(6):601-10.

19. Rottman M, Catherinot E, Hochedez P, et al. Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun. 2007;75(12):5898-907.

20. Yakrus MA, Hernandez SM, Floyd MM, Sikes D, Butler WR, Metchock B. Comparison of Methods for Identification of Mycobacterium abscessus and M. chelonae Isolates. J Clin Microbiol. 2001;39(11):4103-10.

21. McDonnell G, Russell AD. Antiseptics and Disinfectants: Activity, Action, and Resistance. Clin Microbiol Rev. 1999;12(1):147-9.

22. Millstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis. 2008;46(2):274-81.

23. Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis. 2004;39(5):702-9.

24. Williams KJ, Ling CL, Jenkins C, Gillespie SH, McHugh TD. A paradigm for the molecular identification of Mycobacterium species in a routine diagnostic laboratory. J Med Microbiol. 2007;56(Pt 5):598-602.

25. Lin CM, Lin SM, Chung FT, et al. Amplified Mycobacterium tuberculosis direct test for diagnosing tuberculosis pleurisy-a diagnostic accuracy study. PLos One. 2012;79(9):e44842.

26. Yang HJ, Yim HW, Lee MY, Ko KS, Yoon HJ. Mycobacterium conceptionense infection complicating face rejuvenation with fat grafting. J Med Microbiol. 2011;60(Pt 3):371-4.

27. Nakanaga K, Hoshino Y, Era Y, et al. Multiple cases of cutaneous Mycobacterium massiliense infection in a “hot spa” in Japan. J Clin Microbiol. 2011;49(2):613-7.

28. Cavusoglu C, Gurpinar T, Ecemis T. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensitire RAPMYCO panel. New Microbiol. 2012;35(1):73-6.